These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 7936284

  • 1. Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?
    Vidailhet M, Bonnet AM, Marconi R, Gouider-Khouja N, Agid Y.
    Neurology; 1994 Sep; 44(9):1613-6. PubMed ID: 7936284
    [Abstract] [Full Text] [Related]

  • 2. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
    Marconi R, Lefebvre-Caparros D, Bonnet AM, Vidailhet M, Dubois B, Agid Y.
    Mov Disord; 1994 Jan; 9(1):2-12. PubMed ID: 8139601
    [Abstract] [Full Text] [Related]

  • 3. Dyskinesias and the subthalamic nucleus.
    Benabid AL, Benazzouz A, Limousin P, Koudsie A, Krack P, Piallat B, Pollak P.
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S189-92. PubMed ID: 10762147
    [Abstract] [Full Text] [Related]

  • 4. Early morning off-medication dyskinesias, dystonia, and choreic subtypes.
    Cubo E, Gracies JM, Benabou R, Olanow CW, Raman R, Leurgans S, Goetz CG.
    Arch Neurol; 2001 Sep; 58(9):1379-82. PubMed ID: 11559308
    [Abstract] [Full Text] [Related]

  • 5. The effect of stage of Parkinson's disease at the onset of levodopa therapy on development of motor complications.
    Kostić VS, Marinković J, Svetel M, Stefanova E, Przedborski S.
    Eur J Neurol; 2002 Jan; 9(1):9-14. PubMed ID: 11784369
    [Abstract] [Full Text] [Related]

  • 6. L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey.
    Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Meissner WG, Tison F, Rascol O, of the COPARK Study Group.
    Eur J Neurol; 2017 Dec; 24(12):1532-1538. PubMed ID: 28940893
    [Abstract] [Full Text] [Related]

  • 7. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
    Choudhury S, Pradhan R, Paul P, Das M, Gupta A, Ghosh P, Chatterjee S.
    Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
    [Abstract] [Full Text] [Related]

  • 8. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
    Bejjani BP, Arnulf I, Demeret S, Damier P, Bonnet AM, Houeto JL, Agid Y.
    Ann Neurol; 2000 May; 47(5):655-8. PubMed ID: 10805339
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Dyskinesia caused by L-DOPA].
    Derkinderen P, Vidailhet M.
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S92-101. PubMed ID: 12690668
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of two iatrogenic dyskinesias.
    Karson CN, Jeste DV, LeWitt PA, Wyatt RJ.
    Am J Psychiatry; 1983 Nov; 140(11):1504-6. PubMed ID: 6137963
    [Abstract] [Full Text] [Related]

  • 17. Motor complications of chronic levodopa therapy in Parkinson's disease.
    Miyawaki E, Lyons K, Pahwa R, Tröster AI, Hubble J, Smith D, Busenbark K, McGuire D, Michalek D, Koller WC.
    Clin Neuropharmacol; 1997 Dec; 20(6):523-30. PubMed ID: 9403226
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R, Lees AJ.
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [Abstract] [Full Text] [Related]

  • 20. Development of levodopa-induced dyskinesias in parkinsonian monkeys may depend upon rate of symptom onset and/or duration of symptoms.
    Schneider JS, Gonczi H, Decamp E.
    Brain Res; 2003 Nov 14; 990(1-2):38-44. PubMed ID: 14568327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.